The NRG fusion market is rapidly gaining traction as a pivotal area of interest in the field of oncology. This growth is driven by advancements in understanding NRG (Neuregulin) fusions and their role in various cancers. This article delves into the intricacies of the NRG fusion market, exploring its current size, emerging therapies, and future potential. From innovative treatments to market...